Provided by Business Wire
Mar 8, 2021 9:59 PM UTC
CARMAT Announces the Results of Its Capital Increase of â¬55.7 Million After Exercise of the Increase Option
Not for Distribution in the United States of America, Canada, Australia or Japan
Regulatory News:
CARMAT (FR0010907956, ALCAR), the designer and developer of the worldâs most advanced total artificial heart 1, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure (the â Companyâ), today announces the results of its capital increase launched on February 26, 2021 which implemented without shareholdersâ preferential subscription rights by way of a public offering and with a priority subscription period, on an irreducible basis ( à titre irréductible) only, to its existing shareholders and a global offering (the â Offeringâ), for an amount (including the issue premium) of â¬55.
CARMAT Announces the Results of Its Capital Increase of €55 7 Million After Exercise of the Increase Option
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
CARMAT: Availability of the 2020 Universal Registration Document
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.